摘要
肝衰竭是临床常见的严重肝病症候群，病死率极高。人工肝支持系统可大大降低肝衰竭患者病死率，被广泛应用于临床。我国人工肝治疗面临着诸如血源紧缺、血源性疾病增多、肝移植需求增多、治疗观念改变等新形势，单项非生物型人工肝治疗已不能满足临床需要，创新非生物型人工肝治疗模式迫在眉睫。现介绍新形势下非生物型人工肝治疗肝衰竭的变迁与展望。
Liver failure is a common clinical syndrome of serious liver diseases with a high mortality rate. Artificial liver support system can significantly reduce the mortality rate of patients with liver failure and is widely used in clinical practice. Due to the shortage of blood resource, the increase in blood-borne diseases, increased demands for liver transplantation, and the change in treatment concepts, single non-biological artificial liver treatment is often unable to satisfy clinical needs, and it is urgent to develop new therapeutic paradigms of non-bioartificial liver. This article reviews the changes and perspectives of non-biological artificial liver in the treatment of liver failure.
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2017年第9期646-650,共5页
Chinese Journal of Hepatology
关键词
肝
人工
进展
肝功能衰竭
Liver, artificial
Progress
Liver function failure
